Dry Eye Disease Market Share and Growth dry eye disease market is estimated to be valued at USD 7.99 Bn in 2025 and is expected to reach U ...

Eye Infections Treatment MarketThe global eye infections treatment market is projected to grow from USD 8,125.2 million in ...

There are a lot of over-the-counter things you can buy that are FSA-eligible, including products you were probably going to ...

Appio emphasized three strategic pillars for value creation: enhancing operational assets, unlocking the value of Bausch + Lomb equity, and optimizing the capital structure through debt reduction ...

The change reflects the impact of higher sales, partially offset by increased selling, general and administrative expenses in the Bausch + Lomb segment, as well as the goodwill impairment charges ...

"2024 was a year of delivering on our commitments, where we achieved the high-end of our revenue guidance range, and exceeded our adjusted EBITDA excluding Bausch + Lomb, and adjusted operating ...

"2024 was a year of delivering on our commitments, where we achieved the high-end of our revenue guidance range, and exceeded our adjusted EBITDA excluding Bausch + Lomb, and adjusted operating cash ...

"2024 was a year of delivering on our commitments, where we achieved the high-end of our revenue guidance range, and exceeded our adjusted EBITDA excluding Bausch + Lomb, and adjusted operating ...

Bausch + Lomb (BLCO) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.24 per share a year ago.

We apologize, but this video has failed to load. VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live ...

(RTTNews) - Bausch + Lomb Corp. (BLCO), Wednesday announced the financial outlook, expecting revenue of $4.950 billion to $5.050 billion for the fiscal year 2025. Analysts, on average, estimates ...